Recombinant Human MAVS Protein，His & MBP

MAVS (Mitochondrial Antiviral Signaling protein) is a critical adapter protein involved in the innate immune response, particularly in the detection of viral infections. It plays a pivotal role in the signaling pathways triggered by various viral RNA sensors, such as RIG-I and MDA5, leading to the activation of transcription factors like IRF3 and NF-kB, which promote the expression of type I interferons and pro-inflammatory cytokines. Due to its essential function in antiviral immunity, MAVS is a significant focus of research, especially in the context of viral pathogenesis and the development of therapeutic strategies. Understanding the structure and function of MAVS, including its interactions with other proteins and its role in mitochondrial dynamics, can provide insights into how viruses evade host defenses. Recent studies have explored MAVS as a potential target for enhancing antiviral responses or modulating immune responses in various diseases. Recombinant MAVS protein has been utilized in research to dissect its functional mechanisms and to investigate its potential as a biomarker or therapeutic target. The elucidation of MAVS-related pathways could not only improve our understanding of viral infections but also pave the way for innovative approaches in vaccination and immunotherapy. As the field of virology and immunology progresses, ongoing research into MAVS and its signaling networks remains a promising area of inquiry, aiming to harness its mechanisms for better clinical outcomes against viral diseases.